Phase 3 Clinical Trials
Late-stage Phase 3 clinical trial results and data readouts for biotech companies.
May 202643
SHR2554; Chidamide analog tablets Phase 3 Results Expected
Pemetrexed+Cisplatin or Carboplatin Phase 3 Results Expected
Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected
Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected
Remimazolam Tosilate for injection Phase 3 Results Expected
Topical tacrolimus or pimecrolimus Phase 3 Results Expected
June 202657
Short regimen of benznidazole Phase 3 Results Expected
MenACYW135 polysaccharide vaccine Phase 3 Results Expected
Cretostimogene Grenadenorepvec Phase 3 Results Expected
Erythropoiesis-Stimulating Agent (ESA) Phase 3 Results Expected
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level Phase 3 Results Expected
Moxifloxacin / Dexamethasone Ophthalmic Solution Phase 3 Results Expected
About Phase 3 Clinical Trials
Late-stage Phase 3 clinical trial results and data readouts for biotech companies.
What is a Phase 3 Clinical Trial?
Phase 3 trials are large-scale studies that test a drug's efficacy and safety in hundreds to thousands of patients. Positive Phase 3 results typically lead to regulatory submission, while negative results can end a drug's development.